Mild Cognitive Impairment
-
{
- All
- News
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Summer Heat Can Dehydrate You Faster Than You Think: Doctors Explain How To Stay Safe
The summer heat can dehydrate you faster than you think. Here is what Dr Aijaz Ilmi and Dr Meenakshi N explain about dehydration and why people need to hydrate consciously.
-
Alzheimer's Detection Through Plasma Protein Changes Offer Clues To Early Diagnosis: Study
A new type of blood test that analyses the folding of amino acids rather than their amounts may detect earliest biological signs of Alzheimer's disease, according to a study.
-
Can Your Reaction Speed Reveal Brain Health? The 30-Second Test Explained
Reaction time reflects brain processing speed; simple tests like the ruler drop can reveal attention, coordination, and early cognitive changes.
-
Blood Biomarker May Help Predict Women's Dementia Risk 25 Years Before Symptoms: Study
A new study shows blood biomarker ptau217 can predict women's dementia risk up to 25 years before symptoms, offering hope for early prevention and monitoring.
-
Reading, Writing And Learning New Languages May Delay Alzheimer's By Up To 5 Years
The new study says that engaging in activities like reading, writing and learning a language can help to lower the risk of Alzheimer's disease and slower cognitive decline.
-
One in Ten Older Americans Have Dementia, Says Study
Dementia affected one in ten Americans over 65, while 22% had mild cognitive impairment.
-
Controlling Blood Pressure May Reduce Risk Of Cognitive Impairment: Eat These Foods To Manage Blood Pressure
Blood Pressure Diet: According to a recent study, published in the Journal of the American Medical Association, an intensive control of blood pressure in older people reduced the risk of developing mild cognitive impairment, which is a precursor of early dementia.
-
Can A Saliva Test Advance Alzheimer's Disease Diagnosis?
A saliva test would prove useful in clinical settings for its ease and non-invasive nature. Scientists have identified biomarkers in saliva samples that can help in diagnosing mild cognitive impairment and Alzheimer's disease.
-
'Walk Your Way' To Improved Brain Function
According to the study moderate-intensity walking regimen may reduce symptoms of mild cognitive impairment which may be linked to poor blood blood flow in the brain.
-
The Brain's Need for Glucose: Low Levels Could Predict Alzheimer's Risk
A study shows that decline in glucose levels in hippocampus, a region in the brain, appears in the early stages of mild cognitive impairment, predicting Alzheimer's.
-
Muscle Strength May Help to Improve Brain Function
Increased muscle strength may help to improve brain function in adults who suffer from mild cognitive impairment (MCI), shows a new study.
-
Declining Weight During Ageing Linked To Cognitive Impairment
People having a greater weight loss during ageing are at an increased risk of mild cognitive impairment (MCI) which affects the memory, language, thinking and judging capacity of an individual, says a new study.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Summer Heat Can Dehydrate You Faster Than You Think: Doctors Explain How To Stay Safe
The summer heat can dehydrate you faster than you think. Here is what Dr Aijaz Ilmi and Dr Meenakshi N explain about dehydration and why people need to hydrate consciously.
-
Alzheimer's Detection Through Plasma Protein Changes Offer Clues To Early Diagnosis: Study
A new type of blood test that analyses the folding of amino acids rather than their amounts may detect earliest biological signs of Alzheimer's disease, according to a study.
-
Can Your Reaction Speed Reveal Brain Health? The 30-Second Test Explained
Reaction time reflects brain processing speed; simple tests like the ruler drop can reveal attention, coordination, and early cognitive changes.
-
Blood Biomarker May Help Predict Women's Dementia Risk 25 Years Before Symptoms: Study
A new study shows blood biomarker ptau217 can predict women's dementia risk up to 25 years before symptoms, offering hope for early prevention and monitoring.
-
Reading, Writing And Learning New Languages May Delay Alzheimer's By Up To 5 Years
The new study says that engaging in activities like reading, writing and learning a language can help to lower the risk of Alzheimer's disease and slower cognitive decline.
-
One in Ten Older Americans Have Dementia, Says Study
Dementia affected one in ten Americans over 65, while 22% had mild cognitive impairment.
-
Controlling Blood Pressure May Reduce Risk Of Cognitive Impairment: Eat These Foods To Manage Blood Pressure
Blood Pressure Diet: According to a recent study, published in the Journal of the American Medical Association, an intensive control of blood pressure in older people reduced the risk of developing mild cognitive impairment, which is a precursor of early dementia.
-
Can A Saliva Test Advance Alzheimer's Disease Diagnosis?
A saliva test would prove useful in clinical settings for its ease and non-invasive nature. Scientists have identified biomarkers in saliva samples that can help in diagnosing mild cognitive impairment and Alzheimer's disease.
-
'Walk Your Way' To Improved Brain Function
According to the study moderate-intensity walking regimen may reduce symptoms of mild cognitive impairment which may be linked to poor blood blood flow in the brain.
-
The Brain's Need for Glucose: Low Levels Could Predict Alzheimer's Risk
A study shows that decline in glucose levels in hippocampus, a region in the brain, appears in the early stages of mild cognitive impairment, predicting Alzheimer's.
-
Muscle Strength May Help to Improve Brain Function
Increased muscle strength may help to improve brain function in adults who suffer from mild cognitive impairment (MCI), shows a new study.
-
Declining Weight During Ageing Linked To Cognitive Impairment
People having a greater weight loss during ageing are at an increased risk of mild cognitive impairment (MCI) which affects the memory, language, thinking and judging capacity of an individual, says a new study.
